Tezampanel

N/A

Report date: 2024/10/29 10:16:01
NME

Base Information

Drug NameTezampanel
Drug Alias Nametezampanel替占帕奈tezampanelum特扎帕奈NGX-424 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA antagonists
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsOpioid-Related DisordersMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesProniras Corp
Inactive CompaniesTorreypines Therapeutics Inc
Active IndicationsOpioid-Related Disorders
Inactive IndicationsMigraine Disorders

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG